Altamira Therapeutics Achieves COVAMID Trial Target Enrollment for Bentrio in Acute COVID-19

Reached targeted clinical trial enrollment of 136 subjects ahead of scheduleAt current patient enrollment, top-line data read-out is expected in Q3-22HAMILTON, BERMUDA / ACCESSWIRE / June 23, 2022 / Altamira Therapeutics Ltd. (NASDAQ:CYTO), a …